在初级膜性脏病治疗中Rituximab的不同剂量方案:系统性审查

Yi Yu1, Ricong Xu1, Zhijian Li2,3

  • 1Department of Nephrology, The First Affiliated Hospital of Shenzhen University, The Second People's Hospital of Shenzhen, Shenzhen, 518039, People's Republic of China.

概括

原发性膜性病 (PMN) 经常用Rituximab (RTX) 治疗,但最佳剂量尚不清楚. 本综述审查了用于PMN管理的各种RTX方案,以指导未来的治疗策略.